In the face of looming revenue decline from blood cancer medication Revlimid, Indian pharma companies Natco Pharma and Dr.

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several people who developed eye conditions soon after they began taking semaglutide ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

Outside the game, commercials are a big part of Super Bowl Sunday. Companies pay large amounts of money for their ...

Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.

Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...

Brand-name semaglutide (Wegovy and Ozempic) comes in a prefilled injection pen. This pen is single-use and contains the dose of semaglutide that’s appropriate for you at the time. Compounded ...

Semaglutide is probably the best known of the new GLP-1 agonists ... After completing starter doses, maintenance doses for type 2 diabetes range between 0.5 and 2mg weekly. A pre-filled pen containing ...

Other GLP-1 agonists include semaglutide – sold under the brand names Wegovy, Ozempic and Rybelsus. While Mounjaro has shown effectiveness in weight loss, like other GLP-1 agonists, it may cause side ...